BRKR241115P45000
- 0.05
- 0.000.00%
Bruker Corp Newsroom
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
Unusual Options Activity: BRKR, ALK and Others Attract Market Bets, BRKR V/OI Ratio Reaches 178.6
Bruker's (NASDAQ:BRKR) Problems Go Beyond Weak Profit
Trending Industry Today: The Mosaic Leads Losses In Room-Temp Superconductors Stocks
Express News | Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development
Bruker Corporation to Present at Upcoming Investor Conferences
BRKR Stock Declines Despite Launching EpicIF Technology for CellScape
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
Bruker Corp | 10-Q: Q3 2024 Earnings Report
BRKR Misses on Q3 Earnings, Cuts '24 View, Stock Up in Aftermarket
Bruker Analysts Cut Their Forecasts After Q3 Results
Decoding 3 Analyst Evaluations For Bruker
Bruker Price Target Cut to $69.00/Share From $75.00 by Barclays
Bruker Is Maintained at Overweight by Barclays
Express News | Barclays Maintains Overweight on Bruker, Lowers Price Target to $69
Bruker Analyst Ratings
TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Maintains Target Price $70
Stifel Maintains Bruker Corp(BRKR.US) With Hold Rating, Cuts Target Price to $70
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $85
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $69 to $80